Javascript must be enabled to continue!
Designer grass pea for transgene-free minimal neurotoxin-containing seeds with CRISPR-Cas9
View through CrossRef
AbstractGrass pea seeds are consumed as food in several South Asian and Sub-Saharan African nations. However, the presence of the neurotoxic compound N-oxalyl-L-diamino propionic acid (β-ODAP) has restricted its cultivation. Although various cultivars with low β-ODAP levels have been developed, their cultivation is still limited due to the risk of neurolathyrism from long-term grass pea seed ingestion. In this study, we employed the CRISPR-Cas9-mediated gene editing technique to generate grass pea seeds with zero or minimal β-ODAP levels. We targeted theBAHD-AT3gene that encodes a key enzyme in the β-ODAP biosynthesis pathway. We developedbahd-at3knock-out lines using three gRNAs targeting different regions of this gene and characterized them. Cas9-free independent lines from each event carrying the desired on-target mutation were selected and backcrossed twice with the wild-type to eliminate any off-target mutation present therein. Various agronomical parameters were analyzed from the backcrossed mutant lines and they displayed no phenotypic abnormalities. Interestingly, the seed β-ODAP content ranged between 0.001 % - 0.002 % of dry weight which is 99 % lower than the wild-type. Together, our study reports the development of transgene-free, genome-edited grass peas with insignificant levels of β-ODAP in seeds for safer food in the future.
Cold Spring Harbor Laboratory
Title: Designer grass pea for transgene-free minimal neurotoxin-containing seeds with CRISPR-Cas9
Description:
AbstractGrass pea seeds are consumed as food in several South Asian and Sub-Saharan African nations.
However, the presence of the neurotoxic compound N-oxalyl-L-diamino propionic acid (β-ODAP) has restricted its cultivation.
Although various cultivars with low β-ODAP levels have been developed, their cultivation is still limited due to the risk of neurolathyrism from long-term grass pea seed ingestion.
In this study, we employed the CRISPR-Cas9-mediated gene editing technique to generate grass pea seeds with zero or minimal β-ODAP levels.
We targeted theBAHD-AT3gene that encodes a key enzyme in the β-ODAP biosynthesis pathway.
We developedbahd-at3knock-out lines using three gRNAs targeting different regions of this gene and characterized them.
Cas9-free independent lines from each event carrying the desired on-target mutation were selected and backcrossed twice with the wild-type to eliminate any off-target mutation present therein.
Various agronomical parameters were analyzed from the backcrossed mutant lines and they displayed no phenotypic abnormalities.
Interestingly, the seed β-ODAP content ranged between 0.
001 % - 0.
002 % of dry weight which is 99 % lower than the wild-type.
Together, our study reports the development of transgene-free, genome-edited grass peas with insignificant levels of β-ODAP in seeds for safer food in the future.
Related Results
Introduction to CRISPR/Cas9
Introduction to CRISPR/Cas9
Clustered Regularly Interspersed Short Palindromic Repeats (often referred to as CRISPR) is a revolutionary new genome engineering technology that is capable of modifying virtually...
Genome engineering using CRISPR
Genome engineering using CRISPR
Clustered Regularly Interspersed Short Palindromic Repeats (often referred to as CRISPR) is a revolutionary new genome engineering technology that is capable of modifying virtually...
PERKEMBANGAN TEKNOLOGI CRISPR-CAS9 DALAM TERAPI PENYAKIT ANEMIA SEL SABIT PADA MANUSIA - A REVIU
PERKEMBANGAN TEKNOLOGI CRISPR-CAS9 DALAM TERAPI PENYAKIT ANEMIA SEL SABIT PADA MANUSIA - A REVIU
Belum adanya terapi yang menjanjikan atas penyembuhan penyakit genetik anemia sel sabit (Sickle Cell Disease/SCD) yang disebabkan oleh mutasi gen, dan bila dimungkinkan terdapat te...
THE FUTURE OF MEDICINE: ADVANCING GENE THERAPY WITH CRISPR-CAS9’S EXACT PRECISION IN PEDIATRIC MALES
THE FUTURE OF MEDICINE: ADVANCING GENE THERAPY WITH CRISPR-CAS9’S EXACT PRECISION IN PEDIATRIC MALES
The revolutionary potential of CRISPR-Cas9 in medicine lies in its unparalleled precision in gene editing, heralding a new era for treating genetic disorders. This study focuses on...
Application and Prospect of CRISPR-Cas9 Gene Editing Technology in Agricultural Breeding
Application and Prospect of CRISPR-Cas9 Gene Editing Technology in Agricultural Breeding
Since its inception in 2012, the gene editing technology CRISPR-Cas9 has rapidly become a revolutionary tool in the field of gene editing due to its high efficiency, specificity, a...
EVALUATION OF CRISPR/CAS9 GENOME-EDITING SYSTEM IN HUMAN STEM CELLS HSCS: THERAPEUTICS AND DIAGNOSTICS PROSPECTS
EVALUATION OF CRISPR/CAS9 GENOME-EDITING SYSTEM IN HUMAN STEM CELLS HSCS: THERAPEUTICS AND DIAGNOSTICS PROSPECTS
Background: CRISPR/Cas9 genome-editing technology has revolutionized human stem cell (HSC) research, offering novel therapeutic and diagnostic applications. HSCs play a crucial rol...
Linking a rapid throughput plate-assay with high-sensitivity stable-isotope label LCMS quantification permits the identification and characterisation of low β-L-ODAP grass pea lines
Linking a rapid throughput plate-assay with high-sensitivity stable-isotope label LCMS quantification permits the identification and characterisation of low β-L-ODAP grass pea lines
Abstract
Background
Grass pea (Lathyrus sativus) is an underutilised crop with high tolerance to drought and flooding stress and pote...
Alzheimer’s disease: A CRISPR/CAS9-mediated therapeutic approach
Alzheimer’s disease: A CRISPR/CAS9-mediated therapeutic approach
The degenerative nature of Alzheimer's disease (AD) and its severe effects on cognitive function present a major challenge to worldwide healthcare systems. CRISPR/Cas9, one of the ...

